Chemed Corp
NYSE:CHE
Chemed Corp
Cash from Operating Activities
Chemed Corp
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chemed Corp
NYSE:CHE
|
Cash from Operating Activities
$354.4m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
4%
|
CAGR 10-Years
10%
|
|
DaVita Inc
NYSE:DVA
|
Cash from Operating Activities
$1.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-2%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Operating Activities
$1.3B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Operating Activities
$10.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
Cigna Corp
NYSE:CI
|
Cash from Operating Activities
$11.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
19%
|
CAGR 10-Years
19%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Operating Activities
$1.2B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
See Also
What is Chemed Corp's Cash from Operating Activities?
Cash from Operating Activities
354.4m
USD
Based on the financial report for Mar 31, 2024, Chemed Corp's Cash from Operating Activities amounts to 354.4m USD.
What is Chemed Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
10%
Over the last year, the Cash from Operating Activities growth was 32%. The average annual Cash from Operating Activities growth rates for Chemed Corp have been -11% over the past three years , 4% over the past five years , and 10% over the past ten years .